NutriBand (NTRB) Net Cash Flow (2016 - 2026)
NutriBand (NTRB) posted Net Cash Flow of -$568673.0 for Q2 2026, up 22.87% sequentially from -$737320.0 in Q1 2026, and up 57.8% YoY from -$360372.0 in Q2 2025.
NutriBand (NTRB) Net Cash Flow (2016 - 2026) Analysis & Trends
NutriBand has reported Net Cash Flow for 11 years, with the latest figure at -$568673.0 in Q2 2026.
- Quarterly Net Cash Flow rose 57.8% year-over-year to -$568673.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $1.0 million (up 119.36% YoY) and the FY2026 annual result came in at $263138.0, down 93.11% from the prior year.
- Net Cash Flow advanced to -$568673.0 in Q2 2026 per NTRB's latest filing, from -$737320.0 in the prior quarter.
- Over five years, Net Cash Flow peaked at $7.9 million in Q2 2024 and troughed at -$1.7 million in Q4 2025.
- A 5-year average of -$82175.6 and a median of -$754850.5 in 2024 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2024: Net Cash Flow slumped 1333.55% in 2022, then jumped 1210.43% in 2024.
- Over 5 years, Net Cash Flow stood at -$528240.0 in 2022, then sank by 102.41% to -$1.1 million in 2023, then grew by 0.7% to -$1.1 million in 2024, then sank by 58.5% to -$1.7 million in 2025, then jumped by 66.21% to -$568673.0 in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$568673.0, -$737320.0, and -$1.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.65 Bn | 131.79 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 86.08 Bn | 78.09 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | - |
| 4 | Moderna | 63.25 Bn | 58.11 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.26 Bn | 27.95 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.96 Bn | 10.57 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.35 Bn | - | 225.59 Mn |
| 10 | NutriBand | 48.20 Mn | 44.19 Mn | 196,801.00 | -568,673.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -568,673.00 |
| Apr 30, 2026 | -568,673.00 |
| Jan 31, 2026 | -737,320.00 |
| Jan 31, 2026 | -737,320.00 |
| Oct 31, 2025 | -1.68 Mn |
| Oct 31, 2025 | -1.68 Mn |
| Jul 31, 2025 | 4.03 Mn |
| Jul 31, 2025 | 4.03 Mn |
| Apr 30, 2025 | -1.35 Mn |
| Apr 30, 2025 | -1.35 Mn |
| Jan 31, 2025 | -1.39 Mn |
| Jan 31, 2025 | -1.39 Mn |
| Oct 31, 2024 | -1.06 Mn |
| Oct 31, 2024 | -1.06 Mn |
| Jul 31, 2024 | -1.59 Mn |
| Jul 31, 2024 | -1.59 Mn |
| Apr 30, 2024 | 7.85 Mn |
| Apr 30, 2024 | 7.85 Mn |
| Jan 31, 2024 | -772,381.00 |
| Jan 31, 2024 | -772,381.00 |